Resources

Stablepharma and AJ Vaccines have established the primary commercial distribution deal with proposed terms, in relation to the distribution and commercialisation of the SPVX02 (Td) in Europe.

This week, the British Business Bank was pleased to announce that our commercial subsidiary British Patient Capital made its first investment from the Life Sciences Investment Programme into the SV Biotech Crossover Opportunities Fund (SV BCOF). Read this blog to learn more!

Jiva AI describes its platform as a low code/no code platform with interfaces that clinicians with no coding or tech knowledge can easily use.